Follow me on Twitter
I agree that content from Twitter will be displayed to me.
Head of Group
Director of Corporate Program
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Publications
Showing entries 306 - 310 out of 328
Ecker, G, Fleischhacker, W, Schaper, K-J & Chiba, P 1999, 'Artificial neural networks as versatile tools for prediction of MDR-modulatory activity', Advances in Experimental Medicine and Biology, vol. 457, pp. 95-105.
Ecker, G 1999, 'Patent focus on agents for tumour therapy: May - October 1999', Expert Opinion on Therapeutic Patents: authoritative analysis of patenting trends, vol. 9, pp. 1627-1639.
Ecker, G, Chiba, P, Hitzler, M & Schmid, D 1999, 'Structure-activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurements', Biochemical Pharmacology, vol. 58, pp. 1447-1456.
Kratzel, M, Hiessböck, R, Ecker, G, Chiba, P & Hitzler, M 1999, 'Synthesis and in vitro multidrug resistance modulating activity of a series of dihydrobenzopyrans and tetrahydroquinolines', Journal of Medicinal Chemistry, vol. 42, pp. 1921-1926.
Ecker, G, Schmid, D & Chiba, P 1999, 'The importance of a nitrogen atom in modulators of multidrug resistance', Molecular Pharmacology, vol. 56, pp. 791-796.
Projects
Molecular Drug Targets
Hering, S. (Project Lead), Ecker, G. (Co-Lead), Maulide, N. (Co-Lead), Weinzinger, A. (Co-Lead) & Gonzalez Herrero, L. (Co-Lead)
1/12/10 → 31/12/22
Project: Research funding